⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 12, 2023Inflammatory Bowel DiseasesOpen Access

Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not

Priya Sehgal Steven Su John R. Zech Yael R. Nobel Lyndon Luk Ioannis Economou Bo Shen James D. Lewis Daniel E. Freedberg

View Full Paper

Ask AI

Bookmark

Share

Abstract

Visceral adiposity was associated with decreased time to IBD flare, but BMI was not. Future studies could test whether interventions that decrease visceral adiposity will improve IBD disease activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sehgal et al. (2023) studied this question.

synapsesocial.com/papers/69d8f26c2c87b79b92d18410 https://doi.org/10.1093/ibd/izad111

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Large-scale proteomics identifies a pretreatment Crohn’s disease core proteome and a dynamic signature for anti-TNF responseInflammatory Bowel Diseases · Tue,
2Current evidence for first-line advanced therapies in pediatric ulcerative colitis: a critical reviewInflammatory Bowel Diseases · Tue,
3Incidence, risk factors, and treatment patterns of pouchitis in pediatric ulcerative colitisInflammatory Bowel Diseases · Sat,
4Fecal calprotectin changes after polyethylene glycol bowel preparation in patients with ulcerative colitis in remissionInflammatory Bowel Diseases · Wed,
5Biologics, small molecules, and extraintestinal malignancies in inflammatory bowel disease: practical questions and evidence-based answersInflammatory Bowel Diseases · Mon,

More from Inflammatory Bowel Diseases

Long-term outcomes of patients with negative small bowel video capsule endoscopy for Crohn’s disease: A cohort studyFri,
Handheld intestinal ultrasound and the point-of-care question in pediatric IBD: a commentaryTue,
Diet quality, gut microbiome, and inflammatory signatures in Puerto Rican adults with Crohn disease: a multidimensional analysisTue,
Coccidioidomycosis in patients with inflammatory bowel disease receiving advanced therapy: An observational study from an endemic tertiary centerFri,
Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipelineTue,